Apollon Formularies Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Stephen Barnhill
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 3.2yrs |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 2.8yrs |
Recent management updates
Recent updates
CEO
Stephen Barnhill (65 yo)
3.2yrs
Tenure
Dr. Stephen D. Barnhill Jr., M. D., is Chairman and Chief Executive Officer at Apollon Formularies, Ltd. and has been its Director since April 12, 2021. He was Interim President, Chief Executive Officer at...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & CEO | 3.2yrs | no data | no data | |
Chief Science Officer | 2.4yrs | no data | no data | |
Non-Executive Director | 2.4yrs | no data | no data | |
Head of Advisory Board & Consultant | no data | no data | no data | |
Non-Executive Director | 3.2yrs | no data | no data | |
Member of Advisory Board & Consultant | no data | no data | no data |
2.8yrs
Average Tenure
57yo
Average Age
Experienced Board: 73R's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.